Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma

Biomarkers

Volumn 19, Issue 7, 2014, Pages 590-596

  Ren, Wenhao ^a   Qiang, Cui ^a   Gao, Ling ^a   Li, Shao Ming ^a   Zhang, Lin Mei ^a   Wang, Xiao Long ^a   Dong, Jian Wei ^a   Chen, Cheng ^a   Liu, Chang Yang ^a   Zhi, Ke Qian ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Circulating biomarkers; MIR 21; OSCC; PTEN

Indexed keywords

MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR MARKER; MICRORNA; MIRN21 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RISK; CANCER SIZE; CANCER TISSUE; CHEEK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENDER; GINGIVA; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SMOKING; TONGUE; BLOOD; ENZYMOLOGY; EVALUATION STUDY; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOUTH NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84911996436     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.955059     Document Type: Article

References (38)

1. Akobeng AK. (2007). Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644-7.
2. Asaga S, Kuo C, Nguyen T, et al. (2011). Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57:84-91.
3. Avissar M, Christensen BC, Kelsey KT, Marsit CJ. (2009). MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15:2850-5.
4. Calin GA, Croce CM. (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-66.
5. Chen X, Ba Y, Ma L, et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006.
6. Ching-Yu Y, Chien-Yang H, Ming-Feng H, et al. (2013). Evaluating the performance of fibronectin 1 (FN1), integrin a4b1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC). Biomarkers 18: 63-72.
7. Chiu TJ, Chen YJ, Rau KM, et al. (2013). Midkine neurite growthpromoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma. Biomarkers 18:687-98.
8. Denaro N, Lo Nigro C, Natoli G, et al. (2011). The role of p53 and MDM2 in head and neck cancer. ISRN Otolaryngology 2011, Article ID 931813, 1-8.
9. Esquela-Kerscher A, Slack FJ. (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-69.
10. Gordon GJ, Jensen RV, Hsiao LL, et al. (2002). Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 62:4963-7.
11. Heneghan HM, Miller N, Lowery AJ, et al. (2010). Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251:499-505.
12. Hu Z, Chen X, Zhao Y, et al. (2010). Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-6.
13. Keller A, Leidinger P, Gislefoss R, et al. (2011). Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 8:506-16.
14. Lawrie CH, Gal S, Dunlop HM, et al. (2008). Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141:672-5.
15. Li J, Huang H, Sun L, et al. (2009). MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15:3998-4008.
16. Li J, Wang Y, Yu W, et al. (2011). Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 406:70-3.
17. Lingen MW, Kalmar JR, Karrison T, Speight PM. (2008). Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 44:10-22.
18. Liu XG, Zhu WY, Huang YY, et al. (2012). High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 29:618-26.
19. Liu ZL, Wang H, Liu J, Wang ZX. (2013). MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo-or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 372:35-45.
20. Lou Y, Yang X, Wang F, et al. (2010). MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med 26:819-27.
21. Lu L, Byrnes K, Han C, et al. (2014). miR-21 Targets 15-PGDH and promotes cholangiocarcinoma growth. Mol Cancer Res 12:890-900.
22. Markopoulos AK. (2012). Current aspects on oral squamous cell carcinoma. Open Dent J 6:126-30.
23. Maryam E, Vahid R, Nasim TG, Mohamad M. (2012). Prognostic value of transforming growth factor beta 1 [TGF-b1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma. Biomarkers 17:21-7.
24. Meng F, Henson R, Wehbe-Janek H, et al. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-58.
25. Mitchell PS, Parkin RK, Kroh EM, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-18.
26. Nagalakshmi K, Jamil K, Pingali U, et al. (2014). Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC). Biomarkers 19:198-206.
27. Ng EK, Chong WW, Jin H, et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375-81.
28. O-Charoenrat P, Rhys-Evans PH, Eccles SA. (2001). Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127:813-20.
29. Resnick KE, Alder H, Hagan JP, et al. (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112: 55-9.
30. Schmittgen TD, Livak KJ. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-8.
31. Sha M, Ye J, Zhang LX, et al. (2014). Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-kappaB signaling pathway. Pharmacology 93:39-46.
32. Sidransky D. (1997). Nucleic acid based methods for the detection of cancer. Science 278:1054-59.
33. Stroun M, Anker P, Maurice P, et al. (1989). Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46:318-22.
34. van der Waal I, de Bree R, Brakenhoff R, Coebergh JW. (2011). Early diagnosis in primary oral cancer: is it possible Med Oral Patol Oral Cir Bucal 16:e300-5
35. Wang J, Chen J, Chang P, et al. (2009). MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2:807-13.
36. Wang M, Gu H, Wang S, et al. (2012). Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep 5:1514-20.
37. Yang Q, Xu E, Dai J, et al. (2014). miR-21 regulates N-methyl-N-nitro-N0-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2. Toxicol Lett 228:147-56.
38. Zhang HL, Yang LF, Zhu Y, et al. (2011). Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 71:326-31